Hints and tips:
...Normally, hospitals would put people suffering from respiratory illnesses on to nebulisers, a device that turns medication into mist to be inhaled, but they may fear that could spread the virus to other...
...report on how Chinese social media platforms, including Tencent’s WeChat, censored keywords related to coronavirus as early as December. 2 . . . as panic hits the rest of the world Hand sanitiser and respiratory...
...Drugmakers, including Novartis, Sanofi, Teva and Mylan, have said they would ramp up production of the drug and distribute it for compassionate use....
...As well as pain medication and treatments for addiction, Mundipharma sells medicines for cancer, diabetes and respiratory diseases....
...There are civil suits against much larger companies including Johnson & Johnson and Teva, as well as distributors and pharmacies....
...Israel's Teva and Purdue Pharma settled in advance. US politicians alleged WHO guidelines on prescribing were tainted by industry influence....
...For Shirley White, her lungs impaired by chronic respiratory disease, it was a moment to savour: for the first time in years she could walk and talk at the same time....
....; Citron Pharma, LLC; Mayne Pharma (USA), Inc.; Mylan Pharmaceuticals, Inc.; Teva Pharmaceuticals USA; Actavis Holdco U.S., Inc.; Actavis Pharma, Inc.; Ascend Laboratories, LLC; Apotex Corp.; Dr....
...Activist battles 2: Innoviva THE BUSINESS A respiratory drug company that receives royalties from GlaxoSmithKline for its asthma medications....
...Pascal Soriot, AstraZeneca’s chief executive, had moved to reassure investors about his long-term plans, following speculation that he would leave for the top job at Teva, the Israel-based pharmaceuticals...
...He could at least point to strong results elsewhere in Astra’s portfolio in respiratory disease and diabetes as well as other oncology drugs....
...Our clear focus is on commercial execution and preparation for near-term launches in Respiratory, HIV and Vaccines....
...Since then, negative news from two other generic drugmakers, Teva and Mylan, has also weighed on Hikma’s shares....
...Teva Pharmaceuticals showed the way in 2015 when it announced it was buying Gecko Health Innovations for an undisclosed sum....
...As well as GSK’s Nucala, benralizumab is also trailing Teva’s Cinqair, which was approved by the US Food and Drug Administration in March....
...Its main areas of therapeutic focus are respiratory conditions, dermatology, pain and inflammation. Mylan was advised by Centerview and Meda was advised by Rothschild....
...It comes one day after Israel’s Teva Pharmaceutical paid $40.5bn in cash and stock to acquire Allergan’s generic drugs business, cementing its position as the world’s biggest generic medicines group....
...Private equity has not traditionally played in this area, so they will either have to bring in experts or partner with third parties who have the expertise,” said Jeremy Levin, former chief executive of Teva...
...Its portfolio also includes respiratory and erectile dysfunction products....
...It follows Elan’s planned $1bn payment to Theravance, a US-based biotech business, to acquire 21 per cent of the future royalties on four of its experimental respiratory medicines developed in partnership...
...Respiratory drugs accounted for 40 per cent of GSK’s pharmaceuticals sales in 2012, so it is heavily invested in the success of these new treatments....
...Elan’s planned “poison pill” acquisitions – including the purchase of a share of royalties from Theravance , a specialist in respiratory medicines – were all defeated by investors....
...If a majority of Elan’s voting shareholders approve the company’s planned debt issue and deals including the purchase of future royalties in US respiratory specialist Theravance, they will undermine Royalty...
International Edition